The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
3
- 1
Phelps, Charlotte Anne
Born in July 1964Individual (4 offsprings)Officer
2023-06-21 ~ nowOF - Director → CIF 0 - 2
Boutillier, Muriel Francoise Danielle
Born in January 1972Individual (1 offspring)Officer 2023-06-21 ~ nowOF - Director → CIF 0 - 3
Pluntz, Gilles
Born in December 1957Individual (1 offspring)Officer 2023-06-21 ~ nowOF - Director → CIF 0
Ceased
8
- 1
Karnovsky, Roy David
Executive Of Pharmaceutical Co born in October 1949IndividualOfficer 2013-05-30 ~ 2016-06-23OF - Director → CIF 0 - 2
Sempere, Thierry
Company Director born in March 1962IndividualOfficer 2016-06-23 ~ 2021-12-21OF - Director → CIF 0 - 3
Ulmann, Andre Louis Sam, Dr
Company Director born in June 1948Individual (1 offspring)Officer 2014-03-21 ~ 2016-06-23OF - Director → CIF 0 - 4
De Bruijne, Aernout Pepijn
Company Director born in July 1975IndividualOfficer 2021-12-21 ~ 2023-03-31OF - Director → CIF 0 - 5
Van Vranken, Angelia Jo
Executive Of Pharmaceutical Co born in October 1956IndividualOfficer 2013-05-30 ~ 2016-06-23OF - Director → CIF 0Van Vranken, Angelia Jo
IndividualOfficer 2013-05-30 ~ 2016-06-23OF - Secretary → CIF 0 - 6
Ulmann, Marion Sophie
Chief Operating Officer born in July 1980IndividualOfficer 2014-03-21 ~ 2016-06-23OF - Director → CIF 0Ulmann, Marion Sophie
Company Director born in July 1980Individual 2016-07-11 ~ 2023-03-07OF - Director → CIF 0 - 7
Daniel, Wayne Bradley
Venture Capital Executive born in September 1965IndividualOfficer 2013-05-30 ~ 2016-06-23OF - Director → CIF 0 - 8
Quinot, Jean
Company Director born in November 1956IndividualOfficer 2016-06-23 ~ 2021-12-21OF - Director → CIF 0
Company in focus
LINEPHARMA INTERNATIONAL LIMITED
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Fixed Assets - Investments
1 GBP2023-12-31
1 GBP2022-12-31
Fixed Assets
1 GBP2023-12-31
1 GBP2022-12-31
Total Inventories
825,335 GBP2023-12-31
427,403 GBP2022-12-31
Debtors
Non-current
9,532,988 GBP2023-12-31
4,388,258 GBP2022-12-31
Current
6,837,195 GBP2023-12-31
4,819,761 GBP2022-12-31
Cash at bank and in hand
1,178,230 GBP2023-12-31
669,882 GBP2022-12-31
Current Assets
18,373,748 GBP2023-12-31
10,305,304 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-3,403,454 GBP2023-12-31
-1,459,599 GBP2022-12-31
Net Current Assets/Liabilities
14,970,294 GBP2023-12-31
8,845,705 GBP2022-12-31
Total Assets Less Current Liabilities
14,970,295 GBP2023-12-31
8,845,706 GBP2022-12-31
Net Assets/Liabilities
14,970,295 GBP2023-12-31
8,590,491 GBP2022-12-31
Equity
Called up share capital
1,304 GBP2023-12-31
1,304 GBP2022-12-31
1,304 GBP2022-01-01
Share premium
6,365,031 GBP2023-12-31
6,365,031 GBP2022-12-31
6,365,031 GBP2022-01-01
Retained earnings (accumulated losses)
8,603,960 GBP2023-12-31
2,224,156 GBP2022-12-31
2,402,298 GBP2022-01-01
Equity
14,970,295 GBP2023-12-31
8,590,491 GBP2022-12-31
8,768,633 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
7,879,804 GBP2023-01-01 ~ 2023-12-31
2,821,858 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
7,879,804 GBP2023-01-01 ~ 2023-12-31
2,821,858 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
7,879,804 GBP2023-01-01 ~ 2023-12-31
2,821,858 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
7,879,804 GBP2023-01-01 ~ 2023-12-31
2,821,858 GBP2022-01-01 ~ 2022-12-31
Dividends Paid
Retained earnings (accumulated losses)
-1,500,000 GBP2023-01-01 ~ 2023-12-31
-3,000,000 GBP2022-01-01 ~ 2022-12-31
Dividends Paid
-1,500,000 GBP2023-01-01 ~ 2023-12-31
-3,000,000 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
Retained earnings (accumulated losses)
-1,500,000 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
-1,500,000 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation rate used
Furniture and fittings
252023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
4,226 GBP2023-12-31
4,226 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Furniture and fittings
4,226 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
4,226 GBP2023-12-31
Investments in Subsidiaries
1 GBP2023-12-31
1 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
826,568 GBP2023-12-31
2,397,199 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
513,891 GBP2023-12-31
Other Debtors
Current
13,115 GBP2023-12-31
20,726 GBP2022-12-31
Prepayments/Accrued Income
Current
5,483,621 GBP2023-12-31
2,401,836 GBP2022-12-31
Trade Creditors/Trade Payables
Current
57,357 GBP2023-12-31
135,205 GBP2022-12-31
Amounts owed to group undertakings
Current
895,319 GBP2023-12-31
89,682 GBP2022-12-31
Corporation Tax Payable
Current
2,426,595 GBP2023-12-31
661,918 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
24,183 GBP2023-12-31
572,794 GBP2022-12-31
Creditors
Current
3,403,454 GBP2023-12-31
1,459,599 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,008 shares2023-12-31
1,008 shares2022-12-31
Par Value of Share
Class 1 ordinary share
1.002023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
404 shares2023-12-31
404 shares2022-12-31
Par Value of Share
Class 2 ordinary share
0.012023-01-01 ~ 2023-12-31
- Registered number 08550018
LINEPHARMA INTERNATIONAL LIMITED
Info
16 Upper Woburn Place, London WC1H 0BSPRIVATE LIMITED COMPANY incorporated on 2013-05-30 (12 years 7 months). The company status is Active.The last date of confirmation statement was made at 2025-05-30CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.